Data layer emerges as the defining battleground of the AI revolution
The contest for AI supremacy is shifting away from foundation models and toward the data infrastructure sitting beneath…
Variant Bio launches AI-powered platform for drug discovery using genetic data
Jan 6 (Reuters) – Variant Bio, a private biotech firm, said on Tuesday it has launched a platform…
Databricks raises $4B at $134B valuation as its AI business heats up
The IPO window may have cracked open, but it seems some former startups have no intention of going…